Skip to main content
Pragmonica
Special NoticeActive17 days

Sources Sought: Multiple Award IDIQ Construction Contract for Frederick National Laboratory for Cancer Research

Original title: "Sources Sought Notice-Multiple Award IDIQ Construction Contract (FNLCR)

HEALTH AND HUMAN SERVICES, DEPARTMENT OF › NATIONAL INSTITUTES OF HEALTH › NIH NCI

At a glance

The National Cancer Institute, through its prime contractor Leidos Biomedical Research, seeks subcontractors for an indefinite-delivery/indefinite-quantity construction contract at the Frederick National Laboratory for Cancer Research in Frederick, MD. This is a sources sought notice to gauge industry interest and capability; no set-aside is specified. Responses are due by September 18, 2026.

AI-generated summary — verify details in the original notice below and on SAM.gov.

Key details

Notice ID
214429eb79584371a8247f1dc63beeb4
Posted
Response deadline
Archive date
Oct 3, 2026
NAICS
236220 — Commercial And Institutional Building Construction
PSC
Place of performance
Frederick, MD, USA
Contracting office
Bethesda, MD, 20892

Description

National Institutes of Health, National Cancer Institute, Frederick National Laboratory for Cancer Research Opportunities-Special Announcements: Frederick National Laboratory for Cancer Research (FNLCR) Operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute requires an Indefinite Delivery/Indefinite Quantity Subcontract for construction services for the Frederick National Laboratory for Cancer Research (FNLCR). For information concerning opportunities with the FNLCR, please refer to: https://frederick.cancer.gov/work-us/vendors-subcontractors/business-opportunities/multiple-award-idiq-construction-contract-fnlcr or contact the Leidos Biomedical Research Point of Contact listed in this announcement. Background Information: Leidos Biomedical Research, Inc. (Leidos Biomed), a subsidiary of Leidos Corporation, a Delaware corporation with offices in Frederick, MD is the Operations and Technical Support (OTS) contractor for the National Cancer Institute at Frederick. The effort to be performed will be part of Leidos Biomed’s Prime Contract 75N91019D00024 that has been issued by the National Cancer Institute, National Institutes of Health, Frederick, MD. Leidos Biomedical Research, Inc. POC: Contracts Manager at matthew.hull@nih.gov

Documents 1

Files download directly from SAM.gov.